In silico prediction |
Alignment based models |
CasOT [21] |
Adjustable in PAM sequence and the mismatch number (at most 6) |
Conveniently accessable via internet |
Biased toward sgRNA-dependent off-target effects; results need experimental validation |
Cas-OFFinder [22] |
Adjustable in sgRNA length, PAM type, and number of mismatches or bulges |
FlashFry [23] |
Provides information about GC contents |
Crisflash [24] |
High in speed |
Scoring based models |
MIT [15, 25] |
Based on the position of the mismatches to the gRNA |
CCTop [26] |
Based on the distances of the mismatches to the PAM |
CROP-IT [27] |
CFD [28] |
Based on a experimentally validated dataset |
DeepCRISPR [29] |
Considers both sequence and epigenetic feature |
Elevation [30] |
Experimental detection |
Cell-free methods |
Digenome-seq [31–33] |
Digests purified DNA with Cas9/gRNA RNP → WGS |
Highly sensitive |
Expensive; requires high sequencing coverage; requires a reference genome |
DIG-seq [34] |
Uses cell-free chromatin with Digenome-seq pipeline |
Concerning chromatin accessibility; higher validation rate than Digenome-seq |
Extru-seq [35] |
Pre-incubates live cells with Cas9/sgRNA RNP complex→rapidly kill cells by extruder→WGS |
Low miss rate; low false positive rate |
Expensive; difficult to detect Cas9-mediated large deletions, chromosomal depletions, and translocations |
SITE-seq [37] |
A biochemical method with selective biotinylation and enrichment of fragments after Cas9/gRNA digestion |
Minimal read depth; eliminated background; does not require a reference genome |
Low sensitivity; low validation rate |
CIRCLE-seq [38–40] |
Circularizes sheared genomic DNA→incubate with Cas9/gRNA RNP→linearized DNA for NGS |
Cell culture-based methods |
WGS [41–43] |
Sequences the whole genome before and after gene editing |
Comprehensive analysis of the whole genome |
Expensive; limited number of clones can be analyzed |
ChIP-seq [44–47] |
Analyzes binding sites of catalytically inactive dCas9 |
Detection of Cas9 binding sites genome-wide |
Low validation rate; affected by antibody specificity and chromatin accessibility |
IDLV [48–52] |
Integrates IDLV into DSBs |
Detects off-targets in cells that are difficult to transfect |
Low sensitivity; high false positive rate |
GUIDE-seq [36, 53–55] |
Integrates dsODNs into DSBs |
Highly sensitive, low in cost, low false positive rate |
Limited by transfection efficiency |
LAM–HTGTS [57–59] |
Detects DSB-caused chromosomal translocations by sequencing bait-prey DSB junctions |
Accurately detects chromosomal translocations induced by DSBs |
Only detects DSBs with translocation; efficiency limited by chromatin accessibility |
BLESS [60, 61] |
Captures DSBs in situ by biotinylated adaptors |
Directly capture DSBs in situ
|
Only identifies off-target sites at the time of detection |
BLISS [61, 62] |
Captures DSBs in situ by dsODNs with T7 promoter sequence |
Directly capture DSBs in situ; low-input needed |
In vivo detection |
Discover-seq [63] |
Utilizes DNA repair protein MRE11 as bait to perform ChIP-seq |
Highly sensitive; high precision in cells |
Has false positives |
GUIDE-tag [64] |
Uses biotin-dsDNA to mark DSBs |
Highly sensitive; detects off target sites in vivo
|
The incorporation rate of biotin-dsDNA is relatively low (∼6%) |